Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03057964 · ClinicalTrials.gov registry record · NA

PDL and Fractional Photothermolysis for Postsurgical Scars

A NA study of Scar, sponsored by Northwestern University.

Active
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT03057964: Active NA study of Scar, sponsored by Northwestern University.

NCT03057964 is a NA study of Scar that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 76 participants, above the 44-participant average among 15 other Scar trials with a reported enrollment target (73% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03057964, a NA study of Scar, is active but no longer recruiting, sponsored by Northwestern University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

This is a two part study to evaluate the efficacy of early combined PDL (pulsed dye laser) and fractional photothermolysis in the cosmetic improvement of post surgical scars.All subjects will be offered at the time of the dermatologic procedure, an option to treat the post surgical scars with early combined PDL and fractional photothermolysis. Part A is a non-randomized study design and subjects will have the choice of whether or not they will receive treatment. In part B, subjects will be randomized in a 2:1 treatment vs. control design. The experimental group will have a total of 6 visits: 1 standard of care suture removal visit, 3 treatment visits and 2 follow up visits. The control group will have 3 visits: 1 standard of care suture removal visit and 2 follow up visits. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment. This study is a pilot study designed to determine feasibility of this procedure.

Primary Outcome

The POSAS is a series of questions about the scar with a scale from 1 to 10 with 1 as "not at all" or "normal skin" and 10 as "very much so" or "very different".

Conditions Studied

Interventions

  • DEVICE PDL (Pulsed Dye Laser)
  • DEVICE Fractional Photothermolysis Laser

Study Locations (1)

Illinois

  • Northwestern University Feinberg School of Medicine, Department of Dermatology - Chicago

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2017-03-01
Est. Completion 2025-12
Phase NA
Northwestern University

1,209 total trials

What the registry record for NCT03057964 still lists

NCT03057964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, above the 44-participant average among 15 other Scar trials with a reported enrollment target (73% higher).

The record links to 1 condition, with Scar appearing as the primary indexed condition, and to 2 interventions - of which PDL (Pulsed Dye Laser) is the first listed.

NCT03057964 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT03057964 about?

NCT03057964 is a clinical study titled "PDL and Fractional Photothermolysis for Postsurgical Scars". This is a two part study to evaluate the efficacy of early combined PDL (pulsed dye laser) and fractional photothermolysis in the cosmetic improvement of post surgical scars.All subjects will be offered at the time of the dermatologic procedure, an option to treat the post surgical scars with early ...

What is the current status of trial NCT03057964?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2017-03-01. Estimated completion is 2025-12.

What conditions does trial NCT03057964 study?

This clinical trial studies the following conditions: Scar.

What interventions are being tested in trial NCT03057964?

The interventions under investigation include: PDL (Pulsed Dye Laser) (DEVICE), Fractional Photothermolysis Laser (DEVICE).

Who is sponsoring clinical trial NCT03057964?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03057964 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Scar

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03057964's enrollment target sits among peer trials

76 2nd of 15 the highest of 15 other Scar trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Scar trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03057964, the US trial registry maintained by the National Library of Medicine. NCT03057964 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.